title: Red blood cell alloimmunization in sickle cell disease and in thalassaemia: current status, future perspectives and potential role of molecular typing.
abstract: Red blood cell (RBC) transfusions are a milestone in the treatment for sickle cell anaemia (SSA) and for thalassaemia. RBC alloimmunization remains a major challenge of chronic transfusion therapy, and it can lead to adverse life-threatening events. The alloimmunization risk could depend on multiple factors such as the number of transfusions and, most of all, the genetic background. Different ethnic groups are predisposed to immunization because of a significant degree of RBC antigenic mismatch between donor and recipient. There is no universal agreement and standards for the most appropriate selection of RBC units in chronically transfused subjects. Current practice only deals with compatibility of ABO, Rh and K antigens. Molecular RBC antigenic matching extended to other blood group systems is an innovative strategy to ensure a better quality and effectiveness of transfusion therapy.
authors.affiliation: Immunohematology and Transfusion Medicine Unit, Transfusion Medicine Department, San Camillo Forlanini Hospital, Rome, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Matteocci
authors.forename: L
authors.initials: L
authors.lastname: Pierelli
mesh_terms: D000755:Anemia, Sickle Cell / Q000097:blood / Q000276:immunology* / Q000628:therapy; D001787:Blood Group Incompatibility / Q000097:blood / Q000150:complications / Q000276:immunology*; D001788:Blood Grouping and Crossmatching / Q000379:methods / Q000592:standards / Q000639:trends*; D001803:Blood Transfusion / Q000592:standards / Q000639:trends*; D005544:Forecasting; D006801:Humans; D007116:Immunization, Passive / Q000639:trends; D007518:Isoantibodies / Q000096:biosynthesis* / Q000097:blood; D012307:Risk Factors; D013789:Thalassemia / Q000097:blood / Q000276:immunology* / Q000628:therapy; D065227:Transfusion Reaction
chemical_list: D007518:Isoantibodies
keywords: RBC antigens and antibodies; blood groups; genotyping; immunohaematology; transfusion strategy